You may be considering BMAC because pain has continued despite physical therapy, injections, or other treatment—or because you are trying to understand whether there is an alternative to surgery.
The important question is not simply whether BMAC can be injected. It is whether your symptoms are coming from a problem that is appropriate for biologic treatment in the first place.
You may be considering BMAC because pain has continued despite physical therapy, injections, or other treatment—or because you are trying to understand whether there is an alternative to surgery.
At Alypos, treatment begins with physician evaluation to identify what is actually causing your symptoms. If BMAC is appropriate, the bone marrow is harvested, prepared, and precisely delivered under image guidance as part of an individualized treatment plan.
Bone marrow aspiration and concentrate preparation have become increasingly standardized through commercial kits.
Dr. Bernhardt instead uses a physician-controlled protocol developed from years of experience in image-guided interventional pain medicine and regenerative procedures.
Harvest technique, preparation variables, and injection strategy are individualized rather than delegated to a predetermined kit-based workflow.
Diagnosis, patient selection, harvest technique, processing, concentration, image-guided placement, and post-procedure rehabilitation all influence the final result.
At Alypos, these elements are considered together rather than as independent steps.
Bone marrow aspirate concentrate (BMAC) procedures involve minimally invasive marrow aspiration followed by controlled processing and targeted delivery to the affected anatomical structure.
Image guidance is used throughout the procedure to optimize accuracy and procedural safety.
At Alypos, each procedure is performed under high-resolution ultrasound guidance to allow precise placement of regenerative biologic material at the specific structure responsible for pain or dysfunction.
Marrow aspiration is performed using a multi-site, low-volume technique designed to optimize cellular yield and maintain aspirate quality prior to processing.
Large-volume aspiration from a single location increases dilution with peripheral blood.
A low-volume, multi-site technique is intended to maximize marrow quality before processing.
Treatment planning and injection technique are individualized based on patient anatomy, imaging findings, and clinical objectives rather than applied through standardized protocols.
Procedural planning integrates clinical examination with diagnostic imaging to ensure biologic therapy is delivered to a clearly defined anatomical target.
This approach prioritizes precision and appropriate case selection rather than protocol-driven treatment.
Unlike many office-based procedures performed directly on a countertop or procedure tray, biologic preparation at Alypos is performed within a dedicated Class II medical airflow hood designed to provide a controlled preparation environment.
Bone marrow aspiration is only the first step.
How the sample is collected, processed, concentrated, and handled before reinjection can meaningfully influence the biologic composition being delivered.
For that reason, Alypos uses physician-directed preparation rather than relying exclusively on fixed commercial kits.
Preparation is tailored to the clinical situation, including how samples are handled, processed, and timed to support appropriate tissue response.
This preparation environment reflects a procedural standard beyond what is typically found in routine office-based injection practices.
Bone marrow aspirate concentrate (BMAC) therapy at Alypos Regenerative Pain & Wellness in Southlake, Texas is performed as part of a physician-directed regenerative treatment program for selected musculoskeletal conditions.
BMAC may be considered in select orthopedic or degenerative conditions where structural tissue compromise is present and conservative measures have failed. In cases where bone marrow-derived therapy is not ideal, alternative autologous cellular sources may occasionally be evaluated.
As with any medical procedure, BMAC carries risks and limitations that are reviewed during consultation. Response varies among individuals, and no specific outcome can be guaranteed.
BMAC at Alypos is integrated within a broader musculoskeletal and regenerative framework. Decisions regarding its use reflect clinical judgment, experience, and patient-specific factors rather than trends or standardized protocols.
Because biologic therapies are not appropriate for every condition, careful patient evaluation and individualized treatment planning remain central to the Alypos approach.
Precision diagnosis, physician-directed preparation, and accurate image-guided delivery are what determine whether that biologic has the best opportunity to help.
Diagnosis, patient selection, preparation, and precise image-guided delivery all influence whether regenerative treatment has a reasonable opportunity to help.
Candidacy for BMAC is determined through individualized consultation.
Request a Consultation